HHH vs. MPW, MAC, SBRA, GRP.U, SLG, BXMT, CTRE, EPR, APLE, and CUZ
Should you be buying Howard Hughes stock or one of its competitors? The main competitors of Howard Hughes include Medical Properties Trust (MPW), Macerich (MAC), Sabra Health Care REIT (SBRA), Granite Real Estate Inc. Staple (GRP.U), SL Green Realty (SLG), Blackstone Mortgage Trust (BXMT), CareTrust REIT (CTRE), EPR Properties (EPR), Apple Hospitality REIT (APLE), and Cousins Properties (CUZ). These companies are all part of the "real estate investment trusts" industry.
Medical Properties Trust (NYSE:MPW) and Howard Hughes (NYSE:HHH) are both mid-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.
Howard Hughes has higher revenue and earnings than Medical Properties Trust. Howard Hughes is trading at a lower price-to-earnings ratio than Medical Properties Trust, indicating that it is currently the more affordable of the two stocks.
In the previous week, Medical Properties Trust had 18 more articles in the media than Howard Hughes. MarketBeat recorded 22 mentions for Medical Properties Trust and 4 mentions for Howard Hughes. Howard Hughes' average media sentiment score of 1.19 beat Medical Properties Trust's score of 1.12 indicating that Medical Properties Trust is being referred to more favorably in the media.
71.8% of Medical Properties Trust shares are held by institutional investors. Comparatively, 93.8% of Howard Hughes shares are held by institutional investors. 1.5% of Medical Properties Trust shares are held by company insiders. Comparatively, 33.0% of Howard Hughes shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Medical Properties Trust received 412 more outperform votes than Howard Hughes when rated by MarketBeat users. Likewise, 57.84% of users gave Medical Properties Trust an outperform vote while only 20.00% of users gave Howard Hughes an outperform vote.
Medical Properties Trust has a net margin of -2.40% compared to Medical Properties Trust's net margin of -58.21%. Medical Properties Trust's return on equity of -1.59% beat Howard Hughes' return on equity.
Medical Properties Trust presently has a consensus target price of $5.75, indicating a potential upside of 14.77%. Howard Hughes has a consensus target price of $97.00, indicating a potential upside of 43.60%. Given Medical Properties Trust's stronger consensus rating and higher possible upside, analysts clearly believe Howard Hughes is more favorable than Medical Properties Trust.
Medical Properties Trust has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, Howard Hughes has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500.
Summary
Howard Hughes beats Medical Properties Trust on 9 of the 17 factors compared between the two stocks.
Get Howard Hughes News Delivered to You Automatically
Sign up to receive the latest news and ratings for HHH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HHH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Howard Hughes Competitors List
Related Companies and Tools
